FDA issued an EUA on February 24, 2023, for the first at-home OTC diagnostic test that can differentiate and detect influenza A and B and the SARS-CoV-2 virus.

News roundup

What’s the longer-term effect of treatment for critically ill patients with COVID-19? FDA issues guidance on homeopathic drugs. Drug overdose deaths among teenagers surged during the COVID-19 pandemic.

Is buprenorphine or methadone better for opioid use disorder in pregnancy? FDA grants fast track approval for OTC nasal spray. Shingles may increase risk for stroke, heart attack. Study finds benzodiazepines for sleep increased overdose risk for young adults. Recovering COVID patients seem to have elevated risk for newly diagnosed diabetes